Supports hormonal balance, appetite control, and healthy body composition for women’s unique metabolic needs.
Promotes satiety and helps maintain a healthy weight without stimulants or digestive discomfort.
Gentle on the stomach and supports smooth digestion, unlike many fiber-based weight management products.
LLP-1™ is a clinically studied, multi-patented weight management support ingredient formulated using a proprietary blend of highly viscous polysaccharides and esterified fatty acids.
This caffeine- and stimulant-free formula is designed to promote satiety and support weight management.
A clinical study demonstrated that it is well tolerated without the digestive discomfort associated with similar products.
In a clinical study,* LLP-1™ was associated with favorable changes in leptin and adiponectin—hormones that play a key role in satiety and metabolic health.
Called the satiety hormone, is produced by fat cells and helps regulate appetite by signaling to the brain that you are full.
Another hormone made by fat cells, increases fat burning and glucose utilization. In individuals with excess weight, this hormonal system can become disrupted:
Develops, making it harder for the brain to recognize satiety signals. The result? Constant hunger and fat accumulation.
As fat mass increases, reducing the body’s ability to burn fat efficiently and regulate a healthy inflammation response.
Participants taking LLP-1™ during the clinical study lost an average of 21.3 lbs of fat loss vs. 10.8 lbs in the placebo group
Participants taking LLP-1™ during the study experienced an average 3.9” waistline reduction compared to 1.9” in the placebo group
In the clinical study, LLP-1™ was associated with reductions in leptin and increases in adiponectin compared to placebo
LLP-1™ is neutral-flavored and water-dispersible
In one randomized, double-blind, placebo-controlled trial,* LLP-1™ was evaluated in 22 women (11 LLP-1™ participants and 11 placebo) with an average BMI of 32.7 over an eight-week period* alongside a calorie-restricted diet and exercise program. Participants taking LLP-1™ reported greater improvements in measures of satiety and body composition compared to the placebo group, and also experienced greater reductions in fat mass and waist circumference compared to placebo.
The ingredient was well tolerated and did not produce the digestive discomfort sometimes associated with other weight management approaches.
Eur J Appl Physiol (2009), Fragala, et.al. Influences of a dietary supplement in combination with an exercise and diet regimen on adipocytokines and adiposity in women who are overweight.
capsules, tablets, sachets, sticks, wellness shots.
soluble powders, ready‑to‑drink (RTDs), bars, spreads, drink powders, coffee sachets.
Partner with Cyvex to create high-quality, innovative nutraceutical products tailored to your customer’s needs.
Expert help to optimize LLP-1 integration across product formats.
Tailored solutions to meet your specific product goals.
Flexible options to match your scale and budget.
Guidance to ensure your product meets local regulations.
